US WorldMeds Report issue

Contributed to NME For profit Phase 1 Phase 4
Founded: Louisville KY United States (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2006
NCT00235729
First Marketed Drug
2001
nadolol (corgard)
First NDA Approval
2018
lofexidine (lucemyra)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

USWM | US WorldMeds | US WORLDMEDS | US WorldMeds LLC | US WORLDMEDS LLC | US WorldMeds Medical Monitor